Supplier for Medical Genetic Testing Kits and MLPA Reagents

The All Wales Medical Genomics Service (AWMGS) is seeking suppliers for Multiplex Ligation-Dependent Probe Amplification (MLPA) kits and reagents used to identify Copy Number Variations (CNVs)—deletions and duplications—in genetic disorders. MLPA is a diagnostic technology that uses oligonucleotide probe pairs to detect genetic abnormalities through DNA hybridisation, ligation, and PCR amplification, with results analysed via capillary electrophoresis. This testing is essential for clinical decision-making and patient treatment planning. AWMGS has historically sourced these products from a single supplier and is now opening the opportunity to qualified suppliers who can provide high-quality, specialised MLPA probes, reagents, and related molecular diagnostic products that meet rigorous clinical standards. Interested suppliers should demonstrate expertise in molecular diagnostics, quality assurance capabilities, and ability to support routine diagnostic testing across multiple genetic disorder pathways.